Why Axovant's Stock Is Trading Lower Today
Axovant Gene Therapies (NASDAQ: AXGT) shares were trading lower on Tuesday after the company reported its six-month follow-up data from second cohort of SUNRISE-PD Phase 2 trial of AXO-Lenti-PD gene therapy.